C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in C4 Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +14 vs. Q4 2023
- Shares held
- 58.2M
- +11.2M (+23.9%) vs. Q4 2023
- Total value
- $475.6M
- +$210.0M (+79.1%) vs. Q4 2023
- New holders
- 39
- 29 more added
- Sold out
- 25
- 27 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $547.6M |
| Q1 2026 | 123 | $221.3M |
| Q4 2025 | 101 | $152.5M |
| Q3 2025 | 97 | $116.6M |
| Q2 2025 | 102 | $78.2M |
| Q1 2025 | 115 | $102.6M |
| Q4 2024 | 113 | $231.8M |
| Q3 2024 | 118 | $365.9M |
| Q2 2024 | 115 | $281.3M |
| Q1 2024 | 106 | $475.6M |
| Q4 2023 | 92 | $265.6M |
| Q3 2023 | 84 | $64.5M |
| Q2 2023 | 100 | $94.1M |
| Q1 2023 | 121 | $117.5M |
| Q4 2022 | 117 | $231.4M |
| Q3 2022 | 114 | $345.9M |
| Q2 2022 | 113 | $297.2M |
| Q1 2022 | 125 | $904.8M |
| Q4 2021 | 119 | $1.15B |
| Q3 2021 | 113 | $1.54B |
| Q2 2021 | 107 | $1.21B |
| Q1 2021 | 83 | $926.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding C4 Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,920,028 | $23.9M | 0.00% | +920,627+46.0% | Added |
| Commodore Capital LP | 3,410,384 | $27.9M | 1.86% | −389,616−10.3% | Reduced |
| Lynx1 Capital Management LP | 3,634,662 | $29.7M | 7.65% | +500,266+16.0% | Added |
| Wasatch Advisors Inc | 4,328,479 | $35.4M | 0.18% | −2,810,470−39.4% | Reduced |
| Ra Capital Management, L.P. | 4,878,000 | $39.9M | 0.51% | 00.0% | Unchanged |
| State Street Corp | 7,153,280 | $58.4M | 0.00% | +6,997,907+4,503.9% | Added |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −148,610−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −102,379−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −100,984−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −100,370−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −76,800−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −55,602−100.0% | Sold out |
| B. Metzler seel. Sohn & Co. AG | 0 | $0 | 0.00% | −49,037−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −46,286−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −30,200−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −27,960−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −21,981−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,203−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −20,682−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −18,823−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −18,400−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −17,749−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −12,375−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −11,131−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −8,800−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −6,880−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −3,928−100.0% | Sold out |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −200−100.0% | Sold out |